Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

Type Implementing Regulation

Publication 2025-04-22

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


I, the undersigned, official veterinarian, hereby certify that: II.1. The exporting country … (name of exporting country) ⁽¹⁾ II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against these diseases took place during that period; II.1.2. has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against this disease took place during that period. II.2. The semen collection centre ⁽²⁾ described in box I.11. and at which the semen to be exported was collected and stored: II.2.1. met the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC; II.2.2. was operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC. II.3. The [ovine] ⁽³⁾ [caprine] ⁽³⁾ animals standing at the semen collection centre: II.3.1. prior to their stay in the quarantine accommodation described in point II.3.3, ^{(3) (4)} either [II.3.1.1. originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free,] ⁽³⁾ or [II.3.1.1. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC,] ⁽³⁾ or [II.3.1.1. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests ⁽⁵⁾, carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days before entry into the quarantine accommodation,] and have not been kept previously in a holding of a lower status; II.3.1.2. have been kept continuously for at least 60 days on a holding where no case of contagious epididymitis (Brucella ovis) has been diagnosed in the last 12 month period, ⁽³⁾ and [they are animals of the ovine species and have undergone during the 60 days prior to their stay in the quarantine accommodation described in point II.3.3 a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious epididymitis with result of less than 50 ICFTU/ml;] II.3.1.3. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to their stay in the quarantine accommodation described in point II.3.3: (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last 6 months, (b) paratuberculosis and caseous lymphadenitis, within the last 12 month period, (c) pulmonary adenomatosis, within the last 3 years; ⁽³⁾ either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;] ⁽³⁾ or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;] II.3.2. have undergone the following tests carried out on a blood sample collected within the 28 days preceding the commencement of the period of quarantine specified in point II.3.3 for: — brucellosis (B. melitensis), with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella. ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 1.4(c) of Chapter II(II) of Annex D to Directive 92/65/EEC; II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine accommodation specifically approved for the purpose by the competent authority and during that period: II.3.3.1. only animals of at least the same health status were present in the quarantine accommodation; II.3.3.2. the animals have undergone the following tests, carried out by the laboratory approved by the competent authority of the exporting country on samples taken not earlier than 21 days after the animals were admitted to the quarantine accommodation, for: — brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 92/65/EEC; II.3.4. have undergone at least once a year the routine tests for: — brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 5(c) of Chapter II(II) of Annex D to Directive 92/65/EEC. II.4. The semen to be exported was obtained from donor [rams] ⁽³⁾ [bucks] ⁽³⁾ which: II.4.1. were admitted to the approved semen collection centre with the express permission of the centre veterinarian; II.4.2. show no clinical signs of disease on the day of admission to the approved semen collection centre and on the day the semen was collected; ⁽³⁾ either [II.4.3. have not been vaccinated against foot-and-mouth disease during the 12 month period prior to collection of the semen;] ⁽³⁾ or [II.4.3. have been vaccinated against foot-and-mouth disease at least 30 days prior to the collection, and 5% (with a minimum of five straws) of each collection have been submitted to a virus isolation test for foot-and-mouth disease with negative results;] II.4.4. have been kept at an approved semen collection centre for a continuous period of at least 30 days immediately prior to collection of the semen, in the case of collections of fresh semen; II.4.5. have not served naturally after their entry to the quarantine accommodation described in point II.3.3 and up to and including the day of semen collection; II.4.6. have been kept at approved semen collection centres: II.4.6.1. which have been free from foot-and-mouth disease for at least 3 months prior to collection of the semen and 30 days after collection or, in the case of fresh semen, until the date of dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there has been no case of foot-and-mouth disease for at least 30 days prior to collection of the semen; II.4.6.2. which have been free, during the period commencing 30 days prior to collection and ending 30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, from brucellosis (B. melitensis), contagious epididymitis (Brucella. ovis), anthrax and rabies; ⁽³⁾ either [II.4.7. have remained in the exporting country for at least the past 6 months prior to collection of the semen to be exported;] ⁽³⁾ or [II.4.7. during the last 6 months prior to collection of the semen they complied with the animal health conditions applying to donors of the semen which is intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the semen from … ⁽¹⁾;] ⁽³⁾ either [II.4.8. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;] ⁽³⁾ or [II.4.8. were kept during a bluetongue virus seasonally-free period in a seasonally-free zone for at least 60 days prior to, and during collection of the semen;] ⁽³⁾ or [II.4.8. were kept in a vector-protected establishment for at least 60 days prior to, and during collection of the semen;] ⁽³⁾ or [II.4.8. were subjected to a serological test for the detection of antibody to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, on blood samples taken at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;] ⁽³⁾ or [II.4.8. were subjected to an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative results on blood samples taken at commencement and final collection for this consignment of semen and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen;] ^{(3) (6)} either [II.4.9. were resident in the exporting country which according to official findings is free from epizootic haemorrhagic disease (EHD);] ⁽³⁾ or [II.4.9. were resident in the exporting country in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were subjected with negative results in each case to: ⁽³⁾ either [a serological test ⁽⁷⁾ for the detection of antibody to the EHDV group carried out in an approved laboratory on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days after the final collection for this consignment of semen.]] ⁽³⁾ or [a serological test ⁽⁷⁾ for the detection of antibody to the EHDV group, carried out in an approved laboratory on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]] ⁽³⁾ or [an agent identification test ⁽⁷⁾ carried out in an approved laboratory on samples of blood taken at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen.]] II.4.10. comply with the following conditions as regards classical scrapie: II.4.10.1. they have been kept continuously since birth in a country where the following conditions are fulfilled: II.4.10.1.1. classical scrapie is compulsorily notifiable; II.4.10.1.2. an awareness, surveillance and monitoring system is in place; II.4.10.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.4.10.1.4. the feeding to ovine and caprine animals of meat-and-bone meal, or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years; And ⁽³⁾ either [II.4.10.2. they have been kept continuously for the last 3 years preceding the date of the collection of the semen to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the semen to be exported with the requirements set out in points 1.3. (a) to (f) of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;] ⁽³⁾ or [II.4.10.2. they are ovine animals of the ARR/ARR prion protein genotype.] II.5. The semen to be exported: II.5.1. was collected after the date on which the semen collection centre was approved by the competent authority of the exporting country; II.5.2. was collected, processed, preserved, stored and transported in accordance with the requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 92/65/EEC; II.5.3. was sent to the place of loading in a sealed container in accordance with the requirements for semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19. ⁽³⁾ either [II.6. No antibiotics were added to the semen.] ⁽³⁾ or [II.6. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than ⁽⁸⁾: … … .] Notes This animal health certificate is intended for the entry into the Union of semen of ovine and caprine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment were collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre in which the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals. ⁽²⁾ Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽³⁾ Delete if not applicable. ⁽⁴⁾ Only for the third country or territory, or zone thereof appearing with an entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1.). ⁽⁵⁾ Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. ⁽⁶⁾ See remarks for exporting country concerned in Annex I to Decision 2010/472/EU. ⁽⁷⁾ The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. ⁽⁸⁾ Insert names and concentrations.

I, the undersigned, official veterinarian, hereby certify that: II.1. The exporting country … (name of exporting country) ⁽¹⁾ II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia and Rift Valley fever during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against these diseases took place during that period; II.1.2. has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the semen to be exported and until its date of dispatch to the Union and no vaccination against this disease took place during that period. II.2. The semen collection centre ⁽²⁾ described in box I.11. and at which the semen to be exported was collected and stored: II.2.1. met the conditions for the approval of semen collection centres laid down in Chapter I(I)(1) of Annex D to Directive 92/65/EEC; II.2.2. was operated and supervised in accordance with the conditions applicable to semen collection centres and storage centres laid down in Chapter I(II)(1) of Annex D to Directive 92/65/EEC. II.3. The [ovine] ⁽³⁾ [caprine] ⁽³⁾ animals standing at the semen collection centre: II.3.1. prior to their stay in the quarantine accommodation described in point II.3.3, ^{(3) (4)} either [II.3.1.1. originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free,] ⁽³⁾ or [II.3.1.1. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC,] ⁽³⁾ or [II.3.1.1. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests ⁽⁵⁾, carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days before entry into the quarantine accommodation,] and have not been kept previously in a holding of a lower status; II.3.1.2. have been kept continuously for at least 60 days on a holding where no case of contagious epididymitis (Brucella ovis) has been diagnosed in the last 12 month period, ⁽³⁾ and [they are animals of the ovine species and have undergone during the 60 days prior to their stay in the quarantine accommodation described in point II.3.3 a complement fixation test, or any other test with an equivalent documented sensitivity and specificity, to detect contagious epididymitis with result of less than 50 ICFTU/ml;] II.3.1.3. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to their stay in the quarantine accommodation described in point II.3.3: (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides “large colony”), within the last 6 months, (b) paratuberculosis and caseous lymphadenitis, within the last 12 month period, (c) pulmonary adenomatosis, within the last 3 years; ⁽³⁾ either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;] ⁽³⁾ or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;] II.3.2. have undergone the following tests carried out on a blood sample collected within the 28 days preceding the commencement of the period of quarantine specified in point II.3.3 for: — brucellosis (B. melitensis), with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella. ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 1.4(c) of Chapter II(II) of Annex D to Directive 92/65/EEC; II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine accommodation specifically approved for the purpose by the competent authority and during that period: II.3.3.1. only animals of at least the same health status were present in the quarantine accommodation; II.3.3.2. the animals have undergone the following tests, carried out by the laboratory approved by the competent authority of the exporting country on samples taken not earlier than 21 days after the animals were admitted to the quarantine accommodation, for: — brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 92/65/EEC; II.3.4. have undergone at least once a year the routine tests for: — brucellosis (B. melitensis) with negative results in each case in accordance with Annex C to Directive 91/68/EEC; — contagious epididymitis (Brucella ovis), in the case of sheep only, with negative results in each case in accordance with Annex D to Directive 91/68/EEC, or any other test with an equivalent documented sensitivity and specificity; — border disease in accordance with point 5(c) of Chapter II(II) of Annex D to Directive 92/65/EEC. II.4. The semen to be exported was obtained from donor [rams] ⁽³⁾ [bucks] ⁽³⁾ which: II.4.1. were admitted to the approved semen collection centre with the express permission of the centre veterinarian; II.4.2. show no clinical signs of disease on the day of admission to the approved semen collection centre and on the day the semen was collected; ⁽³⁾ either [II.4.3. have not been vaccinated against foot-and-mouth disease during the 12 month period prior to collection of the semen;] ⁽³⁾ or [II.4.3. have been vaccinated against foot-and-mouth disease at least 30 days prior to the collection, and 5% (with a minimum of five straws) of each collection have been submitted to a virus isolation test for foot-and-mouth disease with negative results;] II.4.4. have been kept at an approved semen collection centre for a continuous period of at least 30 days immediately prior to collection of the semen, in the case of collections of fresh semen; II.4.5. have not served naturally after their entry to the quarantine accommodation described in point II.3.3 and up to and including the day of semen collection; II.4.6. have been kept at approved semen collection centres: II.4.6.1. which have been free from foot-and-mouth disease for at least 3 months prior to collection of the semen and 30 days after collection or, in the case of fresh semen, until the date of dispatch, and which are situated in the centre of an area of 10 kilometres radius in which there has been no case of foot-and-mouth disease for at least 30 days prior to collection of the semen; II.4.6.2. which have been free, during the period commencing 30 days prior to collection and ending 30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, from brucellosis (B. melitensis), contagious epididymitis (Brucella. ovis), anthrax and rabies; ⁽³⁾ either [II.4.7. have remained in the exporting country for at least the past 6 months prior to collection of the semen to be exported;] ⁽³⁾ or [II.4.7. during the last 6 months prior to collection of the semen they complied with the animal health conditions applying to donors of the semen which is intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the semen from … ⁽¹⁾;] ⁽³⁾ either [II.4.8. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during, collection of the semen;] ⁽³⁾ or [II.4.8. were kept during a bluetongue virus seasonally-free period in a seasonally-free zone for at least 60 days prior to, and during collection of the semen;] ⁽³⁾ or [II.4.8. were kept in a vector-protected establishment for at least 60 days prior to, and during collection of the semen;] ⁽³⁾ or [II.4.8. were subjected to a serological test for the detection of antibody to the bluetongue virus group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, with negative results, on blood samples taken at least every 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen;] ⁽³⁾ or [II.4.8. were subjected to an agent identification test for bluetongue virus, carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative results on blood samples taken at commencement and final collection for this consignment of semen and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen;] ^{(3) (6)} either [II.4.9. were resident in the exporting country which according to official findings is free from epizootic haemorrhagic disease (EHD);] ⁽³⁾ or [II.4.9. were resident in the exporting country in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and were subjected with negative results in each case to: ⁽³⁾ either [a serological test ⁽⁷⁾ for the detection of antibody to the EHDV group carried out in an approved laboratory on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days after the final collection for this consignment of semen.]] ⁽³⁾ or [a serological test ⁽⁷⁾ for the detection of antibody to the EHDV group, carried out in an approved laboratory on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of semen.]] ⁽³⁾ or [an agent identification test ⁽⁷⁾ carried out in an approved laboratory on samples of blood taken at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of semen.]] II.4.10. comply with the following conditions as regards classical scrapie: II.4.10.1. they have been kept continuously since birth in a country where the following conditions are fulfilled: II.4.10.1.1. classical scrapie is compulsorily notifiable; II.4.10.1.2. an awareness, surveillance and monitoring system is in place; II.4.10.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.4.10.1.4. the feeding to ovine and caprine animals of meat-and-bone meal, or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years; And ⁽³⁾ either [II.4.10.2. they have been kept continuously for the last 3 years preceding the date of the collection of the semen to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the semen to be exported with the requirements set out in points 1.3. (a) to (f) of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;] ⁽³⁾ or [II.4.10.2. they are ovine animals of the ARR/ARR prion protein genotype.] II.5. The semen to be exported: II.5.1. was collected after the date on which the semen collection centre was approved by the competent authority of the exporting country; II.5.2. was collected, processed, preserved, stored and transported in accordance with the requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 92/65/EEC; II.5.3. was sent to the place of loading in a sealed container in accordance with the requirements for semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19. ⁽³⁾ either [II.6. No antibiotics were added to the semen.] ⁽³⁾ or [II.6. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than ⁽⁸⁾: … … .] Notes This animal health certificate is intended for the entry into the Union of semen of ovine and caprine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed according to the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch” Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production” Indicate the date on which semen of the consignment were collected. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre in which the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals. ⁽²⁾ Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽³⁾ Delete if not applicable. ⁽⁴⁾ Only for the third country or territory, or zone thereof appearing with an entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1.). ⁽⁵⁾ Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. ⁽⁶⁾ See remarks for exporting country concerned in Annex I to Decision 2010/472/EU. ⁽⁷⁾ The standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. ⁽⁸⁾ Insert names and concentrations.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 50 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “OV/CAP-OOCYTES-EMB-A-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model OV/CAP-OOCYTES-EMB-A-ENTRY	Certificate model OV/CAP-OOCYTES-EMB-A-ENTRY	Certificate model OV/CAP-OOCYTES-EMB-A-ENTRY	Certificate model OV/CAP-OOCYTES-EMB-A-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify that: II.1. The [oocytes] ⁽¹⁾ [in vivo derived embryos] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I are intended for artificial reproduction and were obtained from donor animals which originate from a third country or territory, or zone thereof: II.1.1. authorised for the entry into the Union of [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ of [ovine] ⁽¹⁾ [caprine] ⁽¹⁾ animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404; ⁽¹⁾ either [II.1.2. where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch;] ^{(1) (2)} or [II.1.2. where foot and mouth disease was not reported for a period starting on the date //____ (dd/mm/yyyy) immediately prior to the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch;] II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch; II.1.4. where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and ⁽¹⁾ either [no vaccination against foot and mouth disease has been carried out for the same period and no vaccinated animals entered into the third country or territory, or zone thereof during that period;] ⁽¹⁾ or [vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.] ⁽¹⁾ [II.2. The [oocytes] ⁽¹⁾ [in vivo derived embryos] ⁽¹⁾ described in Part I have been collected, processed and stored, and dispatched by the embryo collection team ⁽³⁾ which: II.2.1. is approved and listed by the competent authority of the third country or territory; II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.] ⁽¹⁾ [II.2. The [oocytes] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team ⁽³⁾ which: II.2.1. is approved and listed by the competent authority of the third country or territory; II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.] II.3. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I were obtained from donor animals which originate from establishments: II.3.1. free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status. ^{(1) (4)} [II.3.2. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days;] ^{(1) (5)} [II.3.2. which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals kept therein in accordance with procedures provided for in Part 1, points (1) and (2), of Annex II to Commission Delegated Regulation (EU) 2020/688 during at least 12 months and during that period: (i) only caprine animals from establishments applying such surveillance have been introduced therein; ⁽¹⁾ either [(ii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in the animals of the same species kept therein.]] ⁽¹⁾ or [(ii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688.]] II.3.3. in which ⁽¹⁾ either [surra (Trypanosoma evansi) has not been reported in the establishments during the last 2 years.] ⁽¹⁾ or [surra (Trypanosoma evansi) has not been reported during the last 30 days and when the disease was reported in the establishments during the last 2 years, following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments.] II.4. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I were obtained from donor animals which: II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia; II.4.2. remained for at least 6 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ in a third country or territory, or zone thereof referred to in box I.7; II.4.3. for at least 30 days immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and during the [collection] ⁽¹⁾ [production] ⁽¹⁾ period: II.4.3.1. were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals; II.4.3.2. were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in case of ovine animals and those caprine animals which are kept together with ovine animals, ovine epididymitis (Brucella ovis) have not been reported; II.4.3.3. were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.3.1 or from establishments which do not meet the conditions referred to in point II.4.3.2; II.4.3.4. were not used for natural breeding; II.4.4. were examined by the team veterinarian or a team member and did not show symptoms or clinical signs of transmissible animal diseases on the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; II.4.5. are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692; II.4.6. comply with the following conditions as regards foot and mouth disease: II.4.6.1. they come from establishments: (a) situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; (b) in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; ⁽¹⁾ either [II.4.6.2. they were not vaccinated against foot and mouth disease;] ^{(1) (6)} or [II.4.6.2. they were vaccinated against foot and mouth disease during 12 months immediately prior to the date of collection of the embryos and II.4.6.2.1. have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos; II.4.6.2.2. the semen used for fertilisation was collected from a male donor that complies with the conditions set out in Part 5, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686 or the semen complies with the conditions set out in Part 5, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686; II.4.6.2.3. prior to freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual ⁽⁷⁾; II.4.6.2.4. the embryos were stored deep frozen for at least 30 days from the date of collection, and during this period the donor animal has not shown clinical signs of foot and mouth disease;] II.4.7. comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24): ⁽¹⁾ either [II.4.7.1. they have been kept for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months;] ^{(1) (14)} or [II.4.7.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.7.3. they have been kept in a vector-protected establishment for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾] ⁽¹⁾ and/or [II.4.7.4. they have been subjected to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus, with negative results, between 28 and 60 days from the date of each collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.7.5. they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on a blood sample taken on the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] II.4.8. comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV): ⁽¹⁾ either [II.4.8.1. they have been kept for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least the preceding 2 years;] ^{(1) (15)} or [II.4.8.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.8.3. they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ or [II.4.8.4. were resident in the third country or territory of dispatch to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory: ⁽¹⁾ either [II.4.8.4.1. a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, on a blood sample taken between 28 and 60 days from the date of the collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;]] ⁽¹⁾ and/or [II.4.8.4.2. an agent identification test for EHDV, with negative results, on a blood sample taken on the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾.]] ^{(1) (8)} [II.4.9. comply with the following conditions as regards classical scrapie: II.4.9.1. have been kept continuously since birth in a third country or territory where the following conditions are fulfilled: II.4.9.1.1. classical scrapie is compulsorily notifiable; II.4.9.1.2. an awareness, surveillance and monitoring system is in place; II.4.9.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.4.9.1.4. the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced in the whole country for at least 7 years; ⁽¹⁾ either [II.4.9.2. have been kept continuously for the last 3 years preceding the date of the collection of the embryos to be dispatch to the Union in a holding or holdings which has/have fulfilled during that period all the requirements set out in Chapter A, Section A, points 1.3.(a) to (f), of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in in Chapter A, Section A, point 1.3.(c)(iv), of Annex VIII to that Regulation;]] ⁽¹⁾ or [II.4.9.2. they are ovine animals and the embryos carry at least one ARR allele.]] ^{(1) (16)} or [II.4.9.2. they are caprine animals and the embryos carry at least one of the K222, D146 or S146 alleles.]] II.5. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I II.5.1. have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] ⁽¹⁾ [Part 3] ⁽¹⁾ [Part 4] ⁽¹⁾ [Part 5] ⁽¹⁾and Part 6 of Annex III to Delegated Regulation (EU) 2020/686; II.5.2. are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.5.3. are transported in a container which: II.5.3.1. was sealed and numbered prior to the date of dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(1) (8)} [II.5.3.3. has been filled in with a cryogenic agent which has not been previously used for other products; ^{(1) (10)} [II.5.4. are placed in straws or other packages which are securely and hermetically sealed; II.5.5. are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] ^{(1) (11)} [II.6. The [in vivo derived embryos] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing or storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State, and were collected, processed and stored in accordance with the requirements of Part 3, Chapter I and Part 5, Chapters II and III, of Annex II, and Part 1 of Annex III to Delegated Regulation (EU) 2020/686.] ^{(1) (12)} [II.7. The following antibiotic or mixture of antibiotics ⁽¹³⁾ has been added to the collection, processing, washing or storage media: … .] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate: “point II.4.7.4” or “point II.4.7.5”, or both, for EHD-test, indicate: “point II.4.8.4.1” or “point II.4.8.4.2”, or both, if relevant. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽⁴⁾ Applicable for ovine animals. ⁽⁵⁾ Applicable for caprine animals. ⁽⁶⁾ Option available only for the consignment of in vivo derived embryos. ⁽⁷⁾ Manual of the International Embryo Technology Society — A procedural guide and general information for the use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo Technology Society, 1 111 North Dunlap Avenue, Savoy, Illinois 61 874, USA (http://www.iets.org/). ⁽⁸⁾ Delete if the Union is not the final destination of the oocytes and embryos. ⁽⁹⁾ Applicable for frozen oocytes or embryos. ⁽¹⁰⁾ Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine or caprine animals are placed and transported in one container. ⁽¹¹⁾ Does not apply to oocytes. ⁽¹²⁾ Mandatory attestation in case antibiotics were added. ⁽¹³⁾ Insert the name(s) of the antibiotic(s) added and its (their) concentration. ⁽¹⁴⁾ For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽¹⁵⁾ For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽¹⁶⁾ Alternative applicable from 14 April 2024.

I, the undersigned official veterinarian, hereby certify that: II.1. The [oocytes] ⁽¹⁾ [in vivo derived embryos] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I are intended for artificial reproduction and were obtained from donor animals which originate from a third country or territory, or zone thereof: II.1.1. authorised for the entry into the Union of [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ of [ovine] ⁽¹⁾ [caprine] ⁽¹⁾ animals and listed in Annex X to Commission Implementing Regulation (EU) 2021/404; ⁽¹⁾ either [II.1.2. where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch;] ^{(1) (2)} or [II.1.2. where foot and mouth disease was not reported for a period starting on the date //____ (dd/mm/yyyy) immediately prior to the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch;] II.1.3. where infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia were not reported for at least 12 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch; II.1.4. where no vaccination against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out for at least 12 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and until the date of their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and ⁽¹⁾ either [no vaccination against foot and mouth disease has been carried out for the same period and no vaccinated animals entered into the third country or territory, or zone thereof during that period;] ⁽¹⁾ or [vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period.] ⁽¹⁾ [II.2. The [oocytes] ⁽¹⁾ [in vivo derived embryos] ⁽¹⁾ described in Part I have been collected, processed and stored, and dispatched by the embryo collection team ⁽³⁾ which: II.2.1. is approved and listed by the competent authority of the third country or territory; II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 2 of Annex I to Commission Delegated Regulation (EU) 2020/686.] ⁽¹⁾ [II.2. The [oocytes] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I have been collected or produced, processed and stored, and dispatched by the embryo production team ⁽³⁾ which: II.2.1. is approved and listed by the competent authority of the third country or territory; II.2.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/686.] II.3. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I were obtained from donor animals which originate from establishments: II.3.1. free from infection with Brucella abortus, B. melitensis and B. suis and they have never been kept previously in any establishment of a lower health status. ^{(1) (4)} [II.3.2. in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days;] ^{(1) (5)} [II.3.2. which is subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals kept therein in accordance with procedures provided for in Part 1, points (1) and (2), of Annex II to Commission Delegated Regulation (EU) 2020/688 during at least 12 months and during that period: (i) only caprine animals from establishments applying such surveillance have been introduced therein; ⁽¹⁾ either [(ii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported in the animals of the same species kept therein.]] ⁽¹⁾ or [(ii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine animals kept therein and measures were taken in accordance with Part 1, point 3, of Annex II to Delegated Regulation (EU) 2020/688.]] II.3.3. in which ⁽¹⁾ either [surra (Trypanosoma evansi) has not been reported in the establishments during the last 2 years.] ⁽¹⁾ or [surra (Trypanosoma evansi) has not been reported during the last 30 days and when the disease was reported in the establishments during the last 2 years, following the last outbreak, the establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been removed from the establishments.] II.4. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I were obtained from donor animals which: II.4.1. were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia; II.4.2. remained for at least 6 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ in a third country or territory, or zone thereof referred to in box I.7; II.4.3. for at least 30 days immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ and during the [collection] ⁽¹⁾ [production] ⁽¹⁾ period: II.4.3.1. were kept in establishments not situated in a restricted zone established due to the occurrence of foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep pox and goat pox or contagious caprine pleuropneumonia, or of an emerging disease relevant for ovine and caprine animals; II.4.3.2. were kept in a single establishment where infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), rabies, anthrax, surra (Trypanosoma evansi), infection with epizootic haemorrhagic disease virus, infection with bluetongue virus (serotypes 1-24) and, in case of ovine animals and those caprine animals which are kept together with ovine animals, ovine epididymitis (Brucella ovis) have not been reported; II.4.3.3. were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.3.1 or from establishments which do not meet the conditions referred to in point II.4.3.2; II.4.3.4. were not used for natural breeding; II.4.4. were examined by the team veterinarian or a team member and did not show symptoms or clinical signs of transmissible animal diseases on the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; II.4.5. are individually identified as provided for in Article 21(1) of Delegated Regulation (EU) 2020/692; II.4.6. comply with the following conditions as regards foot and mouth disease: II.4.6.1. they come from establishments: (a) situated in an area where foot and mouth disease has not been reported within a 10-km radius centred on the establishments for at least 30 days immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; (b) in which foot and mouth disease has not been reported during at least 3 months immediately prior to the date of [collection] ⁽¹⁾ [production] ⁽¹⁾ of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾; ⁽¹⁾ either [II.4.6.2. they were not vaccinated against foot and mouth disease;] ^{(1) (6)} or [II.4.6.2. they were vaccinated against foot and mouth disease during 12 months immediately prior to the date of collection of the embryos and II.4.6.2.1. have not been vaccinated against foot and mouth disease within at least 30 days immediately prior to the date of collection of the embryos; II.4.6.2.2. the semen used for fertilisation was collected from a male donor that complies with the conditions set out in Part 5, Chapter I, point 1(b), of Annex II to Delegated Regulation (EU) 2020/686 or the semen complies with the conditions set out in Part 5, Chapter I, point 2, of Annex II to Delegated Regulation (EU) 2020/686; II.4.6.2.3. prior to freezing, the embryos have been subjected to trypsin washing carried out in accordance with the recommendations of the IETS Manual ⁽⁷⁾; II.4.6.2.4. the embryos were stored deep frozen for at least 30 days from the date of collection, and during this period the donor animal has not shown clinical signs of foot and mouth disease;] II.4.7. comply with at least one of the following conditions as regards infection with bluetongue virus (serotypes 1-24): ⁽¹⁾ either [II.4.7.1. they have been kept for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾in a third country or territory, or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months;] ^{(1) (14)} or [II.4.7.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.7.3. they have been kept in a vector-protected establishment for at least 60 days immediately prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾] ⁽¹⁾ and/or [II.4.7.4. they have been subjected to a serological test able to detect specific antibodies against all serotypes (1-24) of bluetongue virus, with negative results, between 28 and 60 days from the date of each collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.7.5. they have been subjected to an agent identification test for bluetongue virus (serotypes 1-24), with negative results, on a blood sample taken on the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] II.4.8. comply with at least one of the following conditions as regards infection with epizootic haemorrhagic disease virus (EHDV): ⁽¹⁾ either [II.4.8.1. they have been kept for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ in a third country or territory, or zone thereof where EHDV has not been reported within a radius of 150 km of the establishment for at least the preceding 2 years;] ^{(1) (15)} or [II.4.8.2. they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ and/or [II.4.8.3. they have been kept in a vector-protected establishment for at least 60 days prior to the date of and during collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;] ⁽¹⁾ or [II.4.8.4. were resident in the third country or territory of dispatch to the Union in which according to official findings the following serotypes of EHDV exist: … and have been subjected with negative results in each case to the following tests carried out in an official laboratory: ⁽¹⁾ either [II.4.8.4.1. a serological test able to detect specific antibodies against those serotypes of EHDV, with negative results, on a blood sample taken between 28 and 60 days from the date of the collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾;]] ⁽¹⁾ and/or [II.4.8.4.2. an agent identification test for EHDV, with negative results, on a blood sample taken on the date of collection of the [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾.]] ^{(1) (8)} [II.4.9. comply with the following conditions as regards classical scrapie: II.4.9.1. have been kept continuously since birth in a third country or territory where the following conditions are fulfilled: II.4.9.1.1. classical scrapie is compulsorily notifiable; II.4.9.1.2. an awareness, surveillance and monitoring system is in place; II.4.9.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.4.9.1.4. the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health, has been banned and effectively enforced in the whole country for at least 7 years; ⁽¹⁾ either [II.4.9.2. have been kept continuously for the last 3 years preceding the date of the collection of the embryos to be dispatch to the Union in a holding or holdings which has/have fulfilled during that period all the requirements set out in Chapter A, Section A, points 1.3.(a) to (f), of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were kept at a semen collection centre that complied during that period with the conditions set out in in Chapter A, Section A, point 1.3.(c)(iv), of Annex VIII to that Regulation;]] ⁽¹⁾ or [II.4.9.2. they are ovine animals and the embryos carry at least one ARR allele.]] ^{(1) (16)} or [II.4.9.2. they are caprine animals and the embryos carry at least one of the K222, D146 or S146 alleles.]] II.5. The [oocytes] ⁽¹⁾ [embryos] ⁽¹⁾ described in Part I II.5.1. have been collected, processed and stored in accordance with animal health requirements set out in [Part 2] ⁽¹⁾ [Part 3] ⁽¹⁾ [Part 4] ⁽¹⁾ [Part 5] ⁽¹⁾and Part 6 of Annex III to Delegated Regulation (EU) 2020/686; II.5.2. are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.5.3. are transported in a container which: II.5.3.1. was sealed and numbered prior to the date of dispatch by the embryo collection or production team under responsibility of the team veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(1) (8)} [II.5.3.3. has been filled in with a cryogenic agent which has not been previously used for other products; ^{(1) (10)} [II.5.4. are placed in straws or other packages which are securely and hermetically sealed; II.5.5. are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] ^{(1) (11)} [II.6. The [in vivo derived embryos] ⁽¹⁾ [in vitro produced embryos] ⁽¹⁾ [micromanipulated embryos] ⁽¹⁾ described in Part I were conceived by artificial insemination using semen coming from a semen collection centre, germinal product processing establishment or germinal product storage centre approved for the collection, processing or storage of semen by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State, and were collected, processed and stored in accordance with the requirements of Part 3, Chapter I and Part 5, Chapters II and III, of Annex II, and Part 1 of Annex III to Delegated Regulation (EU) 2020/686.] ^{(1) (12)} [II.7. The following antibiotic or mixture of antibiotics ⁽¹³⁾ has been added to the collection, processing, washing or storage media: … .] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of oocytes or embryos. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which oocytes or embryos of the consignment were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: For BTV-test, indicate: “point II.4.7.4” or “point II.4.7.5”, or both, for EHD-test, indicate: “point II.4.8.4.1” or “point II.4.8.4.2”, or both, if relevant. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Only for a third country or territory, or zone thereof with an opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽⁴⁾ Applicable for ovine animals. ⁽⁵⁾ Applicable for caprine animals. ⁽⁶⁾ Option available only for the consignment of in vivo derived embryos. ⁽⁷⁾ Manual of the International Embryo Technology Society — A procedural guide and general information for the use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo Technology Society, 1 111 North Dunlap Avenue, Savoy, Illinois 61 874, USA (http://www.iets.org/). ⁽⁸⁾ Delete if the Union is not the final destination of the oocytes and embryos. ⁽⁹⁾ Applicable for frozen oocytes or embryos. ⁽¹⁰⁾ Applicable for consignments where oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of ovine or caprine animals are placed and transported in one container. ⁽¹¹⁾ Does not apply to oocytes. ⁽¹²⁾ Mandatory attestation in case antibiotics were added. ⁽¹³⁾ Insert the name(s) of the antibiotic(s) added and its (their) concentration. ⁽¹⁴⁾ For the zones with an entry “SF-BTV” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽¹⁵⁾ For the zones with an entry “SF-EHD” in column 7 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽¹⁶⁾ Alternative applicable from 14 April 2024.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 51 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE ANIMALS COLLECTED OR PRODUCED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 BY THE EMBRYO COLLECTION OR PRODUCTION TEAM BY WHICH THE OOCYTES OR EMBRYOS WERE COLLECTED OR PRODUCED (MODEL “OV/CAP-OOCYTES-EMB-B-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model OV/CAP-OOCYTES-EMB-B-ENTRY -	Certificate model OV/CAP-OOCYTES-EMB-B-ENTRY -	Certificate model OV/CAP-OOCYTES-EMB-B-ENTRY -	Certificate model OV/CAP-OOCYTES-EMB-B-ENTRY -
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned, official veterinarian, hereby certify that: II.1. The exporting country … (name of exporting country) ⁽¹⁾ II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported and until their date of dispatch to the Union and no vaccination against these diseases took place during that period; ⁽²⁾ either [II.1.2. has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and did not carry out vaccination against foot-and-mouth disease during that period;] ⁽²⁾ or [II.1.2. has not been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and/or carried out vaccination against foot-and-mouth disease during that period and the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during 30 days prior to collection and no animal of susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least 30 days after, the [ova] ⁽²⁾ [embryos] ⁽²⁾ were collected and the [ova] ⁽²⁾ [embryos] ⁽²⁾ were not subjected to penetration of zona pellucida;] II.2. The [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported: II.2.1. were [collected] ⁽²⁾ [produced] ⁽²⁾ and processed on premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever in the 30 days immediately prior to their collection; II.2.2. were stored at all times on approved premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until 30 days thereafter; II.2.3. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team described in box I.11., which had been approved and supervised in accordance with the conditions for the approval and supervision of embryo collection teams and embryo production teams ⁽³⁾ laid down in Chapter I(III) of Annex D to Directive 92/65/EEC; II.2.4. meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2.5. come from the donor females of [ovine] ⁽²⁾ [caprine] ⁽²⁾ species which: ⁽²⁾ either [II.2.5.1. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ or [II.2.5.1. were kept during a bluetongue virus seasonally free period in a seasonally free zone;] ⁽²⁾ or [II.2.5.1. were kept protected from the vector for at least 60 days prior to, and during the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ or [II.2.5.1. underwent a serological test for the detection of antibody to the bluetongue virus serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and giving negative results;] ⁽²⁾ or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of the [ova] ⁽²⁾ [embryos] ⁽²⁾ collection or the day of slaughtering and giving negative results;] II.2.5.2. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to collection of the [ova] ⁽²⁾[embryos] ⁽²⁾ to be exported: (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides"large colony"), within the last 6 months; (b) paratuberculosis and caseous lymphadenitis, within the last 12 month period; (c) pulmonary adenomatosis, within the last 3 years; ⁽²⁾ either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;] ⁽²⁾ or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;] II.2.5.3. showed no clinical signs of disease on the day of the [ova] ⁽²⁾ [embryos] ⁽²⁾ collection; ^{(2) (4)} either [II.2.5.4. originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free, and] ⁽²⁾ or [II.2.5.4. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC, and] ⁽²⁾ or [II.2.5.4. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from any clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests ⁽⁵⁾, carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾,] and have not been kept previously in a holding of a lower status; ⁽²⁾ either [II.2.5.5. have remained in the exporting country for at least the past 6 months prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported;] ⁽²⁾ or [II.2.5.5. during the past 6 months prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ they complied with the animal health conditions applying to donors of the [ova] ⁽²⁾ [embryos] ⁽²⁾ which are intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ from … ⁽¹⁾;] II.2.5.6. comply with the following conditions as regards classical scrapie: II.2.5.6.1 they have been kept continuously since birth in a country where the following conditions are fulfilled: II.2.5.6.1.1. classical scrapie is compulsorily notifiable; II.2.5.6.1.2. an awareness, surveillance and monitoring system is in place; II.2.5.6.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.2.5.6.1.4. the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years; And ⁽²⁾ either [II.2.5.6.2 they have been kept continuously for the last 3 years before the collection of the embryos to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the embryos to be exported with the requirements laid down in points (a) to (f) of point 1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;] ⁽²⁾ or [II.2.5.6.2 they are ovine animals and the embryos ⁽²⁾ either [are of the ARR/ARR prion protein genotype;] ⁽²⁾ or [carry at least one ARR allele and were collected after the date of 1 January 2015.]] [II.2.6. were [collected] ⁽²⁾ [produced] ⁽²⁾ in the exporting country, ⁽²⁾ either [II.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]] ^{(2) (6)} or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and the donor females of [ovine] ⁽²⁾ [caprine] ⁽²⁾ species were subjected with negative results in each case to the following tests carried out in an approved laboratory: ⁽²⁾ either [a serological test ⁽⁷⁾ for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of [ova] ⁽²⁾ [embryos] ⁽²⁾;]] ⁽²⁾ or [a serological test ⁽⁷⁾ for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of [ova] ⁽²⁾ [embryos] ⁽²⁾;]] ⁽²⁾ or [an agent identification test ⁽⁷⁾, carried out on samples of blood collected at commencement and conclusion of, and at least every 7 days, if carried out as virus isolation test, or at least every 28 days, if carried out as polymerase chain reaction, during collection for this consignment of [ova] ⁽²⁾[embryos] ⁽²⁾;]] II.2.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo collection team was approved by the competent authority of the exporting country; II.2.8. were processed and stored under approved conditions for at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾ and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2.9. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in box I.19. ⁽²⁾ [II.2.10. the consignment consists of embryos of the ovine or caprine species which were conceived [by artificial insemination] ⁽²⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen coming from semen collection centres approved ⁽⁸⁾ in accordance with: ⁽²⁾ either [II.2.10.1. Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]] ⁽²⁾ or [II.2.10.1. Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production” shall be indicated for in vivo derived embryos and in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre” Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for oocytes/embryos of ovine and caprine animals. ⁽²⁾ Delete as appropriate. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽⁴⁾ Only for the territory appearing with the entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1). ⁽⁵⁾ Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. ⁽⁶⁾ See remarks for exporting third country or territory, or part thereof concerned in Annex III to Decision 2010/472/EU. ⁽⁷⁾ Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. ⁽⁸⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State.

I, the undersigned, official veterinarian, hereby certify that: II.1. The exporting country … (name of exporting country) ⁽¹⁾ II.1.1. has been free from rinderpest, infection with peste des petits ruminants virus, sheep and goat pox, contagious caprine pleuropneumonia, and Rift Valley fever during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported and until their date of dispatch to the Union and no vaccination against these diseases took place during that period; ⁽²⁾ either [II.1.2. has been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and did not carry out vaccination against foot-and-mouth disease during that period;] ⁽²⁾ or [II.1.2. has not been free from foot-and-mouth disease during the 12 month period immediately prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and/or carried out vaccination against foot-and-mouth disease during that period and the donor females come from holdings on which no animal was vaccinated against foot-and-mouth disease during 30 days prior to collection and no animal of susceptible species showed clinical signs of foot-and-mouth disease during the 30 days prior to, and at least 30 days after, the [ova] ⁽²⁾ [embryos] ⁽²⁾ were collected and the [ova] ⁽²⁾ [embryos] ⁽²⁾ were not subjected to penetration of zona pellucida;] II.2. The [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported: II.2.1. were [collected] ⁽²⁾ [produced] ⁽²⁾ and processed on premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis, Rift Valley fever in the 30 days immediately prior to their collection; II.2.2. were stored at all times on approved premises within a 10-km radius of which there was no incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until 30 days thereafter; II.2.3. were [collected] ⁽²⁾ [produced] ⁽²⁾ by the team described in box I.11., which had been approved and supervised in accordance with the conditions for the approval and supervision of embryo collection teams and embryo production teams ⁽³⁾ laid down in Chapter I(III) of Annex D to Directive 92/65/EEC; II.2.4. meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2.5. come from the donor females of [ovine] ⁽²⁾ [caprine] ⁽²⁾ species which: ⁽²⁾ either [II.2.5.1. were kept in a bluetongue virus-free country or zone for at least 60 days prior to, and during collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ or [II.2.5.1. were kept during a bluetongue virus seasonally free period in a seasonally free zone;] ⁽²⁾ or [II.2.5.1. were kept protected from the vector for at least 60 days prior to, and during the collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾;] ⁽²⁾ or [II.2.5.1. underwent a serological test for the detection of antibody to the bluetongue virus serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ and giving negative results;] ⁽²⁾ or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of the [ova] ⁽²⁾ [embryos] ⁽²⁾ collection or the day of slaughtering and giving negative results;] II.2.5.2. to the best of my knowledge do not come from holdings and have not been in contact with animals of a holding, in which, based on the official notification system and according to the written declaration made by the owner, any of the following diseases has been clinically detected within the periods referred to in points (a) to (d) prior to collection of the [ova] ⁽²⁾[embryos] ⁽²⁾ to be exported: (a) contagious agalactia of sheep or goats (Mycoplasma agalactiae, Mycoplasma capricolum, Mycoplasma mycoides var. mycoides"large colony"), within the last 6 months; (b) paratuberculosis and caseous lymphadenitis, within the last 12 month period; (c) pulmonary adenomatosis, within the last 3 years; ⁽²⁾ either [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 3 years;] ⁽²⁾ or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 12 month period, and all the infected animals were slaughtered and remaining animals subsequently reacted negatively to two tests carried out at least 6 months apart;] II.2.5.3. showed no clinical signs of disease on the day of the [ova] ⁽²⁾ [embryos] ⁽²⁾ collection; ^{(2) (4)} either [II.2.5.4. originate from the region described in box I.8, which has been recognised as officially brucellosis (B. melitensis)-free, and] ⁽²⁾ or [II.2.5.4. have belonged to a holding which has obtained and maintained its officially brucellosis (B. melitensis)-free status in accordance with Directive 91/68/EEC, and] ⁽²⁾ or [II.2.5.4. originate from a holding, where in respect of brucellosis (B. melitensis) all susceptible animals have been free from any clinical or any signs of this disease for the last 12 month period, none of the ovine and caprine animals have been vaccinated against this disease, save those vaccinated with Rev. 1 vaccine more than 2 years ago, and all ovine and caprine animals over 6 months of age have been subjected to at least two tests ⁽⁵⁾, carried out with negative results on samples taken on … (date) and on … (date) at least 6 months apart, the latter being within 30 days prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾,] and have not been kept previously in a holding of a lower status; ⁽²⁾ either [II.2.5.5. have remained in the exporting country for at least the past 6 months prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ to be exported;] ⁽²⁾ or [II.2.5.5. during the past 6 months prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ they complied with the animal health conditions applying to donors of the [ova] ⁽²⁾ [embryos] ⁽²⁾ which are intended for export to the Union and they have been imported into the exporting country at least 30 days prior to collection of the [ova] ⁽²⁾ [embryos] ⁽²⁾ from … ⁽¹⁾;] II.2.5.6. comply with the following conditions as regards classical scrapie: II.2.5.6.1 they have been kept continuously since birth in a country where the following conditions are fulfilled: II.2.5.6.1.1. classical scrapie is compulsorily notifiable; II.2.5.6.1.2. an awareness, surveillance and monitoring system is in place; II.2.5.6.1.3. ovine and caprine animals affected with classical scrapie are killed and completely destroyed; II.2.5.6.1.4. the feeding to ovine and caprine animals of meat-and-bone meal or greaves of ruminant origin has been banned and effectively enforced in the whole country for a period of at least 7 years; And ⁽²⁾ either [II.2.5.6.2 they have been kept continuously for the last 3 years before the collection of the embryos to be exported in a holding or holdings which has/have been complying for the last 3 years before the collection of the embryos to be exported with the requirements laid down in points (a) to (f) of point 1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001;] ⁽²⁾ or [II.2.5.6.2 they are ovine animals and the embryos ⁽²⁾ either [are of the ARR/ARR prion protein genotype;] ⁽²⁾ or [carry at least one ARR allele and were collected after the date of 1 January 2015.]] [II.2.6. were [collected] ⁽²⁾ [produced] ⁽²⁾ in the exporting country, ⁽²⁾ either [II.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (EHD);]] ^{(2) (6)} or [II.2.6.1. in which according to official findings the following serotypes of epizootic haemorrhagic disease (EHD) exist: … and the donor females of [ovine] ⁽²⁾ [caprine] ⁽²⁾ species were subjected with negative results in each case to the following tests carried out in an approved laboratory: ⁽²⁾ either [a serological test ⁽⁷⁾ for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken on two occasions not more than 12 months apart prior to and not less than 21 days following collection for this consignment of [ova] ⁽²⁾ [embryos] ⁽²⁾;]] ⁽²⁾ or [a serological test ⁽⁷⁾ for the detection of antibody to the EHD virus serogroup, carried out on samples of blood taken at intervals of not more than 60 days throughout the collection period and between 21 and 60 days after the final collection for this consignment of [ova] ⁽²⁾ [embryos] ⁽²⁾;]] ⁽²⁾ or [an agent identification test ⁽⁷⁾, carried out on samples of blood collected at commencement and conclusion of, and at least every 7 days, if carried out as virus isolation test, or at least every 28 days, if carried out as polymerase chain reaction, during collection for this consignment of [ova] ⁽²⁾[embryos] ⁽²⁾;]] II.2.7. were [collected] ⁽²⁾ [produced] ⁽²⁾ after the date on which the embryo collection team was approved by the competent authority of the exporting country; II.2.8. were processed and stored under approved conditions for at least 30 days immediately after their [collection] ⁽²⁾ [production] ⁽²⁾ and transported under conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 92/65/EEC; II.2.9. were sent to the place of loading in a sealed container in accordance with the requirements for the transport of embryos laid down in point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the number detailed in box I.19. ⁽²⁾ [II.2.10. the consignment consists of embryos of the ovine or caprine species which were conceived [by artificial insemination] ⁽²⁾ [as a result of in vitro fertilisation] ⁽²⁾ using semen coming from semen collection centres approved ⁽⁸⁾ in accordance with: ⁽²⁾ either [II.2.10.1. Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; and the semen complies with the requirements of Directive 92/65/EEC.]] ⁽²⁾ or [II.2.10.1. Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in Part 2 of Annex II to that Decision.]] Notes This animal health certificate is intended for the entry into the Union of oocytes and embryos of ovine and caprine animals, including when the Union is not the final destination of the oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the embryo collection or production team of dispatch of the consignment of oocytes or embryos. Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Species”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate. “Type”: Specify if in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where oocytes or embryos of the consignment are placed. “Date of collection/production” shall be indicated for in vivo derived embryos and in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre” Indicate the unique approval number of the embryo collection or production team by which the oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only third country or territory, or zone thereof listed in Annex X to Commission Implementing Regulation (EU) 2021/404 for oocytes/embryos of ovine and caprine animals. ⁽²⁾ Delete as appropriate. ⁽³⁾ Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm. ⁽⁴⁾ Only for the territory appearing with the entry "V" in column 6 of the table in Part 1 of Annex I to Commission Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1). ⁽⁵⁾ Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. ⁽⁶⁾ See remarks for exporting third country or territory, or part thereof concerned in Annex III to Decision 2010/472/EU. ⁽⁷⁾ Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. ⁽⁸⁾ Only semen collection centres approved by the competent authority of a third country or territory, or zone thereof listed in Annex X to Implementing Regulation (EU) 2021/404 for semen of ovine and caprine animals or by the competent authority of a Member State.


Official veterinarian	Official veterinarian	Official veterinarian	Official veterinarian
Name (in capital letters)
Date		Qualification and title
Stamp		Signature

CHAPTER 52 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF GERMINAL PRODUCTS LISTED BELOW, DISPATCHED AFTER 20 APRIL 2021 FROM THE GERMINAL PRODUCT PROCESSING ESTABLISHMENT:

— semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council and Commission Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of semen of ovine and caprine animals collected, processed and stored in accordance with Council Directive 92/65/EEC before 21 April 2021;

— oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/692 after 20 April 2021;

— stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in accordance with Directive 92/65/EEC before 21 April 2021.

(MODEL “OV/CAP-GP-PROCESSING-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model OV/CAP-GP-PROCESSING-ENTRY	Certificate model OV/CAP-GP-PROCESSING-ENTRY	Certificate model OV/CAP-GP-PROCESSING-ENTRY	Certificate model OV/CAP-GP-PROCESSING-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.